Early Detection Research Network

Lung

IMPDH is a member of a six-autoantibody algorithm for detecting cases of NSCLC among several high-risk populations.
http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/446/374
Under Review
Two
IMPDH is a member of a six group panel consisting of IMPDH, phosphoglycerate mutase, ubiquillin, Annexin I, Annexin II, and HSP70-9B. This six-member panel was found to be the optimal combination of analytes for distinguishing NSCLC patients from the cancer-free controls (with an observed ROC parameter of AUC of 93.4%).
a9495de036864d978e1d1db997eaeb6d
no
no
Contents

There are currently no items in this folder.